CI
TGTX icon

CacheTech Inc’s TG Therapeutics TGTX Stock Holding History

CacheTech Inc’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,107
Closed -$214K – 233
2025
Q4 		$214K Hold
7,107
– – 0.04% 206
2025
Q3 		$257K Hold
7,107
– – 0.05% 159
2025
Q2 		$256K Hold
7,107
– – 0.05% 151
2025
Q1 		$264K Buy
+7,107
New +$239K 0.05% 116

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CacheTech Inc's TGTX Position: Q1 2026 in Review

CacheTech Inc sold out of TG Therapeutics (TGTX) in Q1 2026, closing a stake of 7,107 shares — an estimated $214K sold.

CacheTech Inc first reported a position in TGTX in Q1 2025 and held it in 4 quarters. The position peaked at $264K in Q1 2025. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • CacheTech Inc reported no remaining TG Therapeutics position as of Q1 2026 after selling out during the quarter.
  • CacheTech Inc sold 7,107 TG Therapeutics shares in Q1 2026, an estimated $214K.
  • CacheTech Inc first reported a position in TG Therapeutics in Q1 2025 and held it in 4 quarters.
  • CacheTech Inc's TG Therapeutics position peaked at $264K in Q1 2025.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on CacheTech Inc's 13F filing for Q1 2026, filed 12 May 2026.